GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (STU:TRL) » Definitions » Cyclically Adjusted PS Ratio

DaVita (STU:TRL) Cyclically Adjusted PS Ratio : 1.34 (As of May. 25, 2024)


View and export this data going back to 1995. Start your Free Trial

What is DaVita Cyclically Adjusted PS Ratio?

As of today (2024-05-25), DaVita's current share price is €121.70. DaVita's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €90.50. DaVita's Cyclically Adjusted PS Ratio for today is 1.34.

The historical rank and industry rank for DaVita's Cyclically Adjusted PS Ratio or its related term are showing as below:

STU:TRL' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.78   Med: 1.47   Max: 2.33
Current: 1.34

During the past years, DaVita's highest Cyclically Adjusted PS Ratio was 2.33. The lowest was 0.78. And the median was 1.47.

STU:TRL's Cyclically Adjusted PS Ratio is ranked worse than
53.53% of 340 companies
in the Healthcare Providers & Services industry
Industry Median: 1.195 vs STU:TRL: 1.34

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DaVita's adjusted revenue per share data for the three months ended in Mar. 2024 was €31.198. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €90.50 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


DaVita Cyclically Adjusted PS Ratio Historical Data

The historical data trend for DaVita's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Cyclically Adjusted PS Ratio Chart

DaVita Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.32 1.84 1.52 0.87 1.10

DaVita Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 1.10 1.01 1.10 1.40

Competitive Comparison of DaVita's Cyclically Adjusted PS Ratio

For the Medical Care Facilities subindustry, DaVita's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DaVita's Cyclically Adjusted PS Ratio falls into.



DaVita Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

DaVita's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=121.70/90.5
=1.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, DaVita's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=31.198/131.7762*131.7762
=31.198

Current CPI (Mar. 2024) = 131.7762.

DaVita Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 10.774 100.560 14.119
201409 11.616 100.428 15.242
201412 12.402 99.070 16.496
201503 14.237 99.621 18.832
201506 14.063 100.684 18.406
201509 14.497 100.392 19.029
201512 -1.148 99.792 -1.516
201603 15.466 100.470 20.285
201606 15.904 101.688 20.610
201609 16.061 101.861 20.778
201612 13.007 101.863 16.827
201703 12.598 102.862 16.139
201706 12.385 103.349 15.792
201709 12.120 104.136 15.337
201712 12.714 104.011 16.108
201803 12.709 105.290 15.906
201806 14.194 106.317 17.593
201809 14.589 106.507 18.050
201812 14.901 105.998 18.525
201903 14.556 107.251 17.885
201906 15.083 108.070 18.392
201909 17.429 108.329 21.201
201912 20.015 108.420 24.327
202003 20.263 108.902 24.519
202006 20.613 108.767 24.974
202009 20.028 109.815 24.033
202012 20.639 109.897 24.748
202103 20.806 111.754 24.534
202106 21.725 114.631 24.974
202109 22.739 115.734 25.891
202112 24.862 117.630 27.852
202203 25.455 121.301 27.653
202206 28.318 125.017 29.849
202209 31.933 125.227 33.603
202212 29.970 125.222 31.539
202303 29.012 127.348 30.021
202306 29.645 128.729 30.347
202309 31.100 129.860 31.559
202312 31.092 129.419 31.658
202403 31.198 131.776 31.198

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


DaVita  (STU:TRL) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


DaVita Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of DaVita's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


DaVita (STU:TRL) Business Description

Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

DaVita (STU:TRL) Headlines

No Headlines